evekhm/cms_iom_500 huggingface dataset:
Physician Fee Schedule | CMS
Physicians, Nurses and Allied Health ProfessionalsRural HealthSkilled Nursing Facilities (SNFs)/Long-Term CareSpecial Open Door forumsLook up topicsBack tomenusection title h3MedicareMedicaidCHIPAmerican Indian/Alaska Native CenterQuality of careSpecial populationsFraud & abuseStatesPrivacyHealth conditions & campaignsNew Medicare CardHIPAA Administrative SimplificationLearn MoreBack tomenusection title h3Attend eventsFind resourcesGet trainingFind tools to help you help othersGet digital mediaFind your provider typeBack tomenusection title h3Physicians & other health professionalsFacilitiesHealth & drug plansEmployers & unionsBreadcrumbMedicarePaymentFee schedulesPhysician Fee SchedulePhysician Fee SchedulePages in this sectionFee schedulesPhysician Fee ScheduleLook-Up ToolAdvanced Practice Nonphysician PractitionersAnesthesiologists CenterAudiology ServicesCare ManagementCognitive AssessmentCT Modifier Reduction ListDiagnostic Services by Physical TherapistsEvaluation & Management VisitsGlobal surgery data collectionMarriage and Family Therapists & Mental Health CounselorsMedicare PFS Preventive ServicesOpioid Use Disorder Screening & TreatmentPsychological and Neuropsychological TestsPsychotherapy for CrisisSkin SubstitutesFederal Regulation NoticesCarrier Specific FilesMedicare PFS Locality ConfigurationMedicare PFS Locality Configuration and StudiesMedicare PFS Locality KeyNational Payment Amount FilePFS Relative Value FilesPractice Expense Data & MethodsDMEPOS Fee ScheduleDMEPOS Competitive BiddingAmbulance Fee ScheduleClinical Laboratory Fee SchedulePhysician Fee Schedule
Physician Fee Schedule | CMS
Medicare PFS Locality Configuration and StudiesMedicare PFS Locality KeyNational Payment Amount FilePFS Relative Value FilesPractice Expense Data & MethodsDMEPOS Fee ScheduleDMEPOS Competitive BiddingAmbulance Fee ScheduleClinical Laboratory Fee SchedulePhysician Fee ScheduleOn March 9, 2024, President Biden signed the Consolidated Appropriations Act, 2024, which included a 2.93 percent update to the CY 2024 Physician Fee Schedule (PFS) Conversion Factor (CF) for dates of service March 9 through December 31, 2024. This replaces the 1.25 percent update provided by the Consolidated Appropriations Act, 2023, therefore the CY 2024 CF for dates of service January 1 through March 8, 2024 is $32.74. CMS has implemented the new legislation by adjusting the CY 2023 CF of $33.07 by 2.93 percent and the budget neutrality adjustment for a CY 2024 CF of $33.29 for dates of service March 9 through December 31. CMS is also releasing updated payment files, including the MPFS and associated abstract files, the Ambulatory Surgical Center (ASC) FS, and Anesthesia file.Learn What's New for CY 2024CMS issued theCY 2024 Physician Fee Schedule (PFS)final rule that announces policy changes for Medicare payments under the PFS and other Medicare Part B payment policy issues. See asummary of key provisionseffective January 1, 2024.Frequently asked questions(PDF)about services to help address health-related social needs in the 2024 Physician Fee Schedule final rule:1. Caregiver training2. Social determinants of health risk assessment3. Community health integration4. Principal illness navigationThe PFSistheprimary method ofpaymentforenrolled health careproviders. Medicare uses the PFS when paying:Professional services of physicians and other health care providers in private practiceServices covered incident to physicians services (other than certain drugs covered as incident to services)Diagnostic tests (other than clinical laboratory tests)Radiology servicesCare ManagementFor a one-stop resource focused on new Care Management services under the Physician Fee Schedule, such as chronic care management and transitional care management services, visit theCare Managementwebpage.Physician CenterFor a one-stop resource focused on Medicare Fee-for-Service (FFS) physicians, visit thePhysician Centerwebpage.DownloadsRequest for Information- Reducing Scope of Practice Burden (PDF)Historical MPFSDB Layouts (PDF)
Physician Fee Schedule | CMS
DownloadsRequest for Information- Reducing Scope of Practice Burden (PDF)Historical MPFSDB Layouts (PDF)CY 2019 PFS Proposed Rule Documentation Requirements and Payment for Evaluation and Management Visits and Advancing Virtual Care (PDF)1995 Documentation Guidelines For Evaluation and Management Services (PDF)Primary Care Incentive Program Payments for 2011 (PDF)1997 Documentation Guidelines For Evaluation and Management Services (PDF)Place of Service Codes for Professional Claims (PDF)Primary Care Incentive Program Payments for 2012 (PDF)FAQ on Billing G0453 for Remote Intraoperative Neurophysiology Monitoring (PDF)FAQs for CR 7502: Medicares 3-Day Payment Window and the Impacts on Wholly Owned or Wholly Operated Physician Practices (PDF)Development of A Validation Model for RVUs (PDF)FAQ for Mammography Services - Updated 1/18/17 (PDF)Related LinksCPEP Files - 02/23/2006HCPCS Level FileExample Calculation FileTelehealthPhysician CenterMedicare FFS Physician Feedback Program/Value-Based Payment ModifierTherapy ServicesPage Last Modified:03/18/2024 03:18 PMHelp with File Formats and Plug-InsfooterGet email updatesSign up to get the latest information about your choice of CMS topics. You can decide how often to receive updates.EmailSign up - opens in a new windowSign upThe cms_footer region can contain a variable number of menusMenus placed in this region should use the same template fileCMS & HHS WebsitesCMS & HHS WebsitesMedicare.govMedicaid.govInsureKidsNow.govHealthCare.govHHS.govHHS.gov/OpenAbout CMSAbout CMSAbout UsCareersNewsroomBlogPodcastToolsToolsAcronymsArchiveContactsGlossaryHelpful LinksHelpful LinksPrivacy PolicyPlain LanguagePrivacy SettingsNondiscrimination & AccessibilityDeveloper InformationVulnerability Disclosure PolicyUSA Government SitesUSA Government SitesFreedom of Information ActNo Fear ActInspector GeneralUSA.govConnect with CMSLinkedin linkYoutube linkFacebook link!Font Awesome Free 6.5.1 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free Copyright 2024 Fonticons, Inc.Twitter linkRSS Feed link
Physician Fee Schedule | CMS
RSS Feed linkA federal government website managed and paid for by the U.S. Centers for Medicare & Medicaid Services.7500 Security Boulevard, Baltimore, MD 21244
Article - Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57849)
CMS National Coverage PolicyN/AArticle TextThis article is effective immediately.Tomosynthesis-guided percutaneous core needle biopsy utilizes the technique of digital breast tomosynthesis or 3-D mammography for identification of appropriate target sampling and intra-procedural needle placement. However, although digital breast tomosynthesis has become a more common screening and diagnostic modality; use of this technology for percutaneous breast biopsy is still on the rise. As a result, there may be uncertainty as to the proper coding and billing, since this procedure does not have a specifically assigned CPT code.It is Noridians experience that the billing and coding of this procedure is at high risk for error. Therefore, Noridian is providing billing and coding guidance for providers who perform tomosynthesis-guided percutaneous biopsy for the evaluation of abnormal breast tissue concerning for malignancy.If tomosynthesis is the only imaging guidance used for a breast biopsy, CPT code 19499 (Unlisted procedure, breast) should be utilized and the name of the procedure documented in the comments/narrative field for the followingPart Bclaim field/types:Loop 2400 or SV101-7 for the 5010A1 837PItem 19 for paper claimCPT code 19499 (Unlisted procedure, breast) should be utilized and the name of the procedure documented in the comments/narrative field for the followingPart Aclaim field/types:Line SV202-7 for 837I electronic claimBlock 80 for the UB04 claim form
Article - Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57849)
Block 80 for the UB04 claim formShould more than one lesion of either breast be biopsied using tomosynthesis-only guidance on the same date of service, modifier 59 should be coded if the additional lesion is on the same breast (e.g. 19499 and 19499-59 should be coded to indicate 2 separate lesions undergoing tomosynthesis-guided breast biopsy) or modifier -50 indicating bilateral procedure,if repeated on the opposite breast. The additional lesion(s) requiring biopsy (including which breast) must be clearly documented in the procedure note. Multiple surgery payment rules applied.If a percutaneous breast biopsy is performed using both stereotactic and tomosynthesis imaging guidance, CPT code 19081 (Biopsy, breast, with placement of breast localization device(s) (eg, clip, metallic pellet), when performed, and imaging of the biopsy specimen, when performed, percutaneous; first lesion, including stereotactic guidance) should be utilized.Should it be clinically necessary to use additional non-mammography imaging guidance to biopsy a breast lesion(s) either of the same or opposite breast, on the same date of service, this procedure will be denied unless modifier -59 (e.g. 19499-59) is also coded along with the additional imaging modality respective CPT code. Documentation provided must clearly support the need to switch modalities. Examples include: ultrasound-guided percutaneous breast biopsy CPT 19083-19084, MRI-guided percutaneous breast biopsy CPT 19085-19086, percutaneous biopsy without imaging guidance CPT 19100, and open incisional biopsy CPT 19101.In addition, CPT codes 19281-19288, related to the placement of a breast localization device (e.g. clip, metallic pellet, wire/needle, radioactive seeds) are not separately payable with 19499 as these procedure codes are considered part of the tomosynthesis-guided percutaneous breast biopsy procedure.Similarly, if a tomosynthesis-only guided placement of a breast localization device procedure is performed (without biopsy), CPT 19499 will also need to be utilized with clear description in the comments/narrative field for bothPart A and Part Bclaims.
Article - Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57849)
Another issue is the common practice of obtaining a post-biopsy mammogram to confirm marker placement, assess for complications, etc. It is Noridians interpretation that a follow-up mammogram performed post tomosynthesis-guided breast biopsy will be considered part of the procedure and not separately payable, regardless of whether the patient is brought to a different room and/or unit for the mammography.Post- biopsy mammograms (77065 and/or 77067, with or without G0279) coded and billed for the same date of service, regardless of the timing, separation, number, and/or order of claims billed, will not be considered separately payable.Should either 19499 and/or 77065/77067 be coded and billed on separate claims, resulting in one of the codes being paid prior, additional payment by Noridian for the other billed service will be subject to payment adjustment and/or denial, taking previous payment into consideration.ReferencesCurrent Procedural Terminology (CPT) ManualCPT Assistant 2019 - Frequently Asked Questions, December 2016, Volume 26, Issue 12, page 16
Article - Billing and Coding: MolDX: HLA Testing for Transplant Histocompatibility (A57851)
CMS National Coverage PolicyCMS Internet-Only Manual, Pub 100-04, Medicare Claims Processing Manual, Inpatient Hospital Billing, Chapter 3, Section 90 Billing Transplant ServicesTitle 42 CFR 412 Prospective Payment Systems for Inpatient Hospital ServicesArticle Text
Article - Billing and Coding: MolDX: HLA Testing for Transplant Histocompatibility (A57851)
Article TextMedicare covers the following solid organ transplants: kidney, heart, lung, heart/lung, liver, pancreas, pancreas/kidney, and intestinal/multi-visceral. Medicare also covers stem cell transplants for certain conditions.Claims for CPT codes used to describe Human Leukocyte Antigen (HLA) testing used for transplant histocompatibility testing will be denied. See below for further explanation on correct billing for these services. This does not refer to HLA testing for non-transplant services.HLA testing for histocompatibility testing as part of transplantation are part of solid organ acquisition services.Services for organ transplants must be billed as described in the Centers for Medicare and Medicaid Services (CMS) Internet-Only Manual, Pub 100-04, Medicare Claims Processing Manual, Inpatient Hospital Billing, Chapter 3 Section 90 and as described in the Electronic Code of Federal Regulations, Title 42, Public Health, Part 412 Prospective Payment Systems for Inpatient Hospital Services. The acquisition costs of hearts, kidneys, livers, lungs, pancreas, and intestines (or multivisceral organs) incurred by approved transplantation centers are paid on a reasonable cost basis by approved transplant centers; they are not billed as stand-alone laboratory services.HLA typing is a component of the acquisition services for an allogeneic stem cell transplant as well. Payment for these acquisition services is included in the MS-DRG payment for the allogeneic stem cell transplant when the transplant occurs in the inpatient setting and in the OPPS APC payment for the allogeneic stem cell transplant when the transplant occurs in the outpatient setting. The Medicare contractor does not make separate payment for these acquisition services, because hospitals may bill and receive payment only for services provided to the Medicare beneficiary who is the recipient of the stem cell transplant and whose illness is being treated with the stem cell transplant. Unlike the acquisition costs of solid organs for transplant (e.g., hearts and kidneys), which are paid on a reasonable cost basis, acquisition costs for allogeneic stem cells are included in prospective payment.Acquisition charges do not apply to autologous transplants.HLA CPT codes unrelated to transplant testing have coverage as outlined in the following Local Coverage Determinations (LCDs):
Article - Billing and Coding: MolDX: HLA Testing for Transplant Histocompatibility (A57851)
CPT 81381  The MolDX: Pharmacogenomics Testing L38435 LCD addresses limited coverage for gene-drug interactions.CPT 81383  The MolDX: HLA-DQB1*06:02 Testing for Narcolepsy L37003 LCD addresses non-coverage of HLA-DQB1*06:02 typing for the diagnosis or management of narcolepsy.
Article - Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors (A57858)
CMS National Coverage PolicyTitle XVIII of the Social Security Act, 1833(e), prohibits Medicare payment for any claim lacking thenecessary documentation to process the claim.CMS Internet-Only Manual, Pub. 100-02, Medicare Benefit Policy Manual, Chapter 15, 80.1.2 A/B MAC (B) Contacts With Independent Clinical LaboratoriesCMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 16, 50.5Jurisdiction of Laboratory Claims, 60.1.1 Independent Laboratory Specimen Drawing, 60.2. Travel Allowance.CMS Internet-Only Manual, Pub. 100-04, Medicare Claims Processing Manual, Chapter 23, 10 Reporting ICD Diagnosis and Procedure CodesArticle TextThe information in this article contains billing, coding or other guidelines that complement the Local Coverage Determination (LCD) for MolDX: Next Generation Sequencing for Solid Tumors L38158.Relevant Article: Billing and Coding: MolDX: Testing of Multiple Genes A57880:To report a Next Generation Sequencing for Solid Tumors service, please submit the following claim information:Select the appropriate CPT codeEnter 1 unit of service (UOS)Enter the appropriate DEX Z-Code identifier adjacent to the CPT code in the comment/narrative field for the following Part B claim field/types:Loop 2400 or SV101-7 for the 5010A1 837PBox 19 for paper claimEnter the appropriate DEX Z-Code identifier adjacent to the CPT code in the comment/narrative field for the following Part A claim field/types:Line SV202-7 for 837I electronic claimBlock 80 for the UB04 claim formSelect the appropriate ICD-10-CM codeNOTE:When entering the DEX Z-Code on the SV101-7 documentation field for Part B claims please do not add additional characters and/or information on the line.
Article - Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (A57863)
CMS National Coverage PolicyN/AArticle Text
Article - Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (A57863)
This article contains coding and other guidelines that complement the Local Coverage Determination (LCD) for Micro-Invasive Glaucoma Surgery (MIGS).Coding Information:Procedure codes may be subject to National Correct Coding Initiative (NCCI) edits or OPPS packaging edits. Refer to NCCI and OPPS requirements prior to billing Medicare.For services requiring a referring/ordering physician, the name and NPI of the referring/ordering physician must be reported on the claim.A claim submitted without a valid ICD-10-CM diagnosis code will be returned to the provider as an incomplete claim under Section 1833(e) of the Social Security Act.The diagnosis code(s) must best describe the patient's condition for which the service was performed.Specific Coding Guideline:According to Current Procedural Terminology (CPT), in this setting a 'device' is a 'stent'. Therefore, to comply with coverage requirements set forth in the Local Coverage Determination the stent(s) must be inserted on the same date of service as the cataract surgery and billed accordingly on the same claim.Insertion of these devices not in conjunction with cataract surgery services is considered investigational and will be denied.For insertion of the XEN45 bill 0449T. Insertion of more than one XEN45 device per eye in a given surgical session (each additional device represented by CPT 0450T) is considered investigational and not covered.Since there is no specific CPT code for goniopuncture or so-called microgoniotomy procedures, the unlisted CPT code 66999 (unlisted procedure, anterior segment of the eye) should be reported in these instances.Any procedures performed which consists of single or multiple small punctures and/or injections of small amounts of viscoelastic, or other limited interventions should be reported using unlisted CPT code 66999.Specifically, goniotomy (CPT code 65820) should not be coded in addition to other angle surgeries, stent insertions or Schlemm canal implants or if the incision into the trabecular meshwork is minimal or simply incidental to another procedure.In order to report a goniotomy, an extensive incision of the trabecular meshwork around the eye, at the least and generally more than 3 clock hours, must have been performed.
Article - Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (A57863)
In order to report a goniotomy, an extensive incision of the trabecular meshwork around the eye, at the least and generally more than 3 clock hours, must have been performed.Documentation regarding the reasonable and necessary premise for the work must be present. Noridian may request additional documentation on a case-by-case basis.Documentation Requirements:The patient's medical record must contain documentation that fully supports the medical necessity for services included in the LCD. (See "Indications and Limitations of Coverage.") This documentation includes, but is not limited to, relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures. The medical record and/or test results documenting medical necessity should be maintained and made available on request. iStent, iStent inject, and Hydrus must be performed in conjunction with cataract surgery on the same date of service and documented in the medical record.
Article - Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (A57864)
CMS National Coverage PolicyN/AArticle Text
Article - Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (A57864)
This article contains coding and other guidelines that complement the Local Coverage Determination (LCD) for Micro-Invasive Glaucoma Surgery (MIGS).Coding Information:Procedure codes may be subject to National Correct Coding Initiative (NCCI) edits or OPPS packaging edits. Refer to NCCI and OPPS requirements prior to billing Medicare.For services requiring a referring/ordering physician, the name and NPI of the referring/ordering physician must be reported on the claim.A claim submitted without a valid ICD-10-CM diagnosis code will be returned to the provider as an incomplete claim under Section 1833(e) of the Social Security Act.The diagnosis code(s) must best describe the patient's condition for which the service was performed.Specific Coding Guideline:According to Current Procedural Terminology (CPT), in this setting a 'device' is a 'stent'. Therefore, to comply with coverage requirements set forth in the Local Coverage Determination, the stent(s) must be inserted on the same date of services as the cataract surgery and billed accordingly on the same claim.Insertion of these devices not in conjunction with cataract surgery services is considered investigational and will be denied.For insertion of the XEN45 bill 0449T. Insertion of more than one XEN45 device per eye in a given surgical session (each additional device represented by CPT 0450T) is considered investigational and not covered.Since there is no specific CPT code for goniopuncture or so-called microgoniotomy procedures, the unlisted CPT code 66999 (unlisted procedure, anterior segment of the eye) should be reported in these instances.Any procedures performed which consists of single or multiple small punctures and/or injections of small amounts of viscoelastic, or other limited interventions should be reported using unlisted CPT code 66999.Specifically, goniotomy (CPT code 65820) should not be coded in addition to other angle surgeries, stent insertions or Schlemm canal implants or if the incision into the trabecular meshwork is minimal or simply incidental to another procedure.In order to report a goniotomy, an extensive incision of the trabecular meshwork around the eye, at the least and generally more than 3 clock hours, must have been performed.
Article - Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS) (A57864)
In order to report a goniotomy, an extensive incision of the trabecular meshwork around the eye, at the least and generally more than 3 clock hours, must have been performed.Documentation regarding the reasonable and necessary premise for the work must be present. Noridian may request additional documentation on a case-by-case basis.Documentation Requirements:The patient's medical record must contain documentation that fully supports the medical necessity for services included in the LCD. (See "Indications and Limitations of Coverage.") This documentation includes, but is not limited to, relevant medical history, physical examination, and results of pertinent diagnostic tests or procedures. The medical record and/or test results documenting medical necessity should be maintained and made available on request. iStent, iStent inject, and Hydrus must be performed in conjunction with cataract surgery on the same date of service and documented in the medical record.